Physician profile
Carlo B Bifulco
NPI 1528057155
$19,137.48
in general payments reported to CMS, 2019-2025
12 companies · $1,498 in 2025
The $1,498 reported for 2025 was more than what 76% of Anatomic Pathology providers received nationally (typical 2025 total: $110).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2022: $10K · 2023: $2,507 · 2024: $4,610 · 2025: $1,498.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,419 · Travel and Lodging: $2,219 · Food and Beverage: $1,977.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,419.00 |
| Travel and Lodging | $2,218.57 |
| Food and Beverage | $1,976.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Illumina, INC. | $8,089.81 | 2022-2024 | Oncology Testing |
| Genzyme Corporation | $5,396.00 | 2022 | |
| Merck Sharp & Dohme LLC | $2,850.32 | 2022-2025 | Keytruda |
| Agilent Technologies, INC. | $1,145.00 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $642.73 | 2023-2025 | Tagrisso |
| Caris Mpi, INC. | $303.63 | 2025 | Mi Cancer Seek |
| Foundation Medicine, INC. | $297.38 | 2022-2023 | |
| Regeneron Healthcare Solutions, INC. | $125.00 | 2019 | |
| Pfizer INC. | $114.10 | 2024 | |
| Tempus Ai, INC | $63.34 | 2024 | Xt Cdx |
| Abbvie INC. | $60.43 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $49.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlo Bifulco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.